INS and myeloid sarcoma: In a clinical trial evaluating the efficacy of FMT in adolescents with MS, FMT improved insulin sensitivity and glucose metabolism, with a 34% improvement in HOMA‐IR, a 29% reduction in fasting insulin levels, and a 7% decrease in fasting blood glucose (FBG) after 6‐week intervention.